Related Subjects:
|DNA replication
|DNA structure in Nucleus
|Cell Cycle
|Mitosis and Meiosis
|Ribosomes
|Microtubules
|Mitochondria
|Smooth and Rough Endoplasmic Reticulum
𧬠Genetic mutations are permanent changes in the DNA sequence.
They may be germline (inherited, present in all cells) or somatic (acquired, restricted to certain tissues, e.g. cancer).
Mutations are a major source of genetic diversity but also underlie many human diseases.
π§Ύ Types of Genetic Mutations
- Point Mutations π― :
- Single nucleotide change.
- Types:
- Missense β one amino acid replaced by another (e.g. sickle cell anaemia, HBB gene).
- Nonsense β premature stop codon β truncated protein (e.g. Duchenne muscular dystrophy).
- Silent β no amino acid change (due to codon redundancy) but may affect splicing or mRNA stability.
- Insertions & Deletions (Indels) ββ :
- Extra or missing nucleotides.
- If not multiple of 3 β frameshift β altered reading frame (e.g. Tay-Sachs disease).
- Copy Number Variations (CNVs) π :
- Large segments duplicated or deleted (e.g. Charcot-Marie-Tooth disease type 1A).
- Chromosomal Mutations π§© :
- Deletions (Cri-du-chat, 5p deletion).
- Duplications.
- Inversions.
- Translocations (Philadelphia chromosome in CML: t(9;22)).
- Aneuploidy (trisomy 21 β Down syndrome; monosomy X β Turner syndrome).
β οΈ Causes of Mutations
- Spontaneous :
- Replication errors (mismatch, slippage).
- Spontaneous base deamination/oxidation.
- Induced :
- Radiation (UV β thymine dimers; X-rays β double-strand breaks).
- Chemicals (alkylating agents, tobacco carcinogens).
- Biological (retroviruses inserting into host genome).
π Consequences of Mutations
- Beneficial π : e.g. CCR5-Ξ32 mutation β resistance to HIV.
- Neutral βοΈ : Silent or non-coding variants with no effect on fitness.
- Harmful β : Disease-causing β cancer (p53 mutation), metabolic disorders, congenital syndromes.
π§ͺ Examples of Genetic Disorders
- Single-Gene :
- Cystic fibrosis (CFTR mutations, ΞF508).
- Sickle cell disease (HBB missense mutation).
- Huntingtonβs disease (CAG trinucleotide repeat expansion, HTT gene).
- Chromosomal :
- Down syndrome (trisomy 21).
- Turner syndrome (45,X).
- Klinefelter syndrome (47,XXY).
- Complex / Multifactorial :
- Diabetes, heart disease, schizophrenia β polygenic + environmental influence.
π Detection & Analysis
- Genetic testing β PCR, Sanger sequencing, FISH, karyotyping, microarrays.
- Next-Generation Sequencing (NGS) β high-throughput, used for cancer panels, rare disease diagnosis.
- Whole exome/genome sequencing β research & clinical applications.
π Clinical Relevance
- Personalised Medicine π― :
- EGFR, KRAS, BRAF mutations β guide targeted cancer therapies.
- Pharmacogenomics (e.g. TPMT mutation β azathioprine toxicity).
- Gene Therapy π οΈ :
- CRISPR-Cas9 and viral vectors used to correct defective genes (e.g. in SCID).
- Cancer π¬ :
- Mutations in tumour suppressors (p53, BRCA1/2) and oncogenes (RAS, MYC) drive oncogenesis.
- Targeted therapies (imatinib in CML, PARP inhibitors in BRCA mutations).
π Summary
Genetic mutations may be point, indel, CNV, or chromosomal.
They arise spontaneously or from environmental damage.
Consequences range from neutral to beneficial to disease-causing.
Understanding mutations is vital in genetics, oncology, pharmacology, and personalised medicine.